← Leaderboards
Thomas P Hedman
Ampac Biotechnology
$1,182,411
Attributed
$1,182,411
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $408.5K · FY2007–13$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,182,411 · 4
By mechanism
R44$767,902 · 1
R43$315,615 · 2
R41$98,894 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Fatigue”
- Peter J. Snyder · University Of Pennsylvania$32,402,680
- Arie Kapteyn · Rand Corporation$20,740,048
- Michael R Irwin · University Of California San Diego$19,048,945
- Edward G Shaw · Wake Forest University Health Sciences$15,941,725
- Christine A. Miaskowski · University Of California San Francisco$14,953,251
- Natasha Bassam Halasa · Vanderbilt University Medical Center$14,934,787
Research focus
FatigueCrosslinkBiomaterial CompatibilityNutritionalLow Back PainMechanicsIn VivoInjectableIntervertebral Disc StructureIn VitroDesignDigestionBack PainDisabilityClinical TrialsBaseAgedExtracellular MatrixCollagenCattleInjection Of Therapeutic AgentCostJointsOperative Surgical Procedures
Grant awards (5)
Crosslink augmentation to resist snoring and obstructive sleep apnea syndrome$244,897
R43 · FY2013 · HL · contact PI
Injectable collagen crosslink augmentation for degenerative disc disease$359,441
R44 · FY2011 · AR · contact PI
Injectable collagen crosslink augmentation for degenerative disc disease$408,461
R44 · FY2010 · AR · contact PI
Nonsurgical Exogenous Crosslink Therapy for Intervertebral Disc Disease$70,718
R43 · FY2007 · AR · contact PI
Modification of Intervertebral Disk Fatigue Resistance$98,894
R41 · FY2001 · AR